IGIV Therapy:
Current Clinical Practice and Future Directions
 
Date: December 3, 2007
Time: 5:30 PM – 7:30 PM
CE Provider: Continuing Education Alliance

IGIV Therapy: Current Clinical Practice and Future Directions will familiarize pharmacists with current trends in the usage of immune globulin intravenous (IGIV), the rationale and mechanisms for prioritization of IGIV use, the strength of evidence supporting IGIV therapy for myasthenia gravis and other neurologic disorders, and the clinical strategies for anticipating and managing adverse events by tailoring treatment to each patient's risk profile. Faculty for this continuing education activity include Jordan S. Orange, MD, PhD; Carol Lee Koski, MD; and Jerry Siegel, PharmD, FASHP.

 

		Download Registration Brochure

Site developed and maintained by CE Alliance
©2007 CE Alliance. Last updated on October 26, 2007